Ruxolitinib is typically administered orally in the form of tablets. The dosage and frequency depend on the specific condition being treated, the patient's overall health, and their response to the medication. Regular follow-up appointments are necessary to monitor the drug's effectiveness and adjust the dosage as needed.
